T. Rowe Price Investment Management
CDMO

T. Rowe Price Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

T. Rowe Price Investment Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,352,252
Closed -$28.3M – 662
2023
Q4 		$28.3M Buy
4,352,252
+253,385
+6% +$1.63M 0.02% 456
2023
Q3 		$38.7M Buy
4,098,867
+183,000
+5% +$2.2M 0.03% 401
2023
Q2 		$54.7M Buy
3,915,867
+177,981
+5% +$3.03M 0.04% 366
2023
Q1 		$70.1M Buy
3,737,886
+130,233
+4% +$2.14M 0.05% 317
2022
Q4 		$49.7M Buy
3,607,653
+1,965,560
+120% +$30.1M 0.04% 355
2022
Q3 		$31.4M Buy
+1,642,093
New +$29.9M 0.03% 399

Other funds holding CDMO

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.77% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

T. Rowe Price Investment Management's CDMO Position: Q1 2024 in Review

T. Rowe Price Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 4,352,252 shares — an estimated $28.3M sold.

T. Rowe Price Investment Management first reported a position in CDMO in Q3 2022 and held it in 6 quarters. The position peaked at $70.1M in Q1 2023. 167 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • T. Rowe Price Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 4,352,252 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $28.3M.
  • T. Rowe Price Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • T. Rowe Price Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $70.1M in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2024, filed 15 May 2024.